Sunit Talapatra


Dr. Sunit Talapatra’s practice focuses on the intellectual property needs of diverse technology clients spanning pharmaceuticals, diagnostics, agriculture, food and nutrition, and medical devices. He also has a unique perspective on European companies with ties to the United States, having lived in the Netherlands and frequently returning to the continent. He is a partner in the firm’s Chemical, Biotechnology & Pharmaceutical, and Private Equity & Venture Capital Practices as well as the Health Care & Life Sciences Sector.

In addition to patent counseling and prosecution matters, Sunit has argued several cases before the United States Patent Trial and Appeal Board, notably orchestrating a successful defense in the “1st-Ever” Pharma AIA Ruling (Amneal Pharma Inc v. Supernus Pharma Inc.). Some of his exemplary patent cases include Chatterjee v. Tabor (interference proceeding re DNA polymerase); Keygene NV v. Floragenex, Inc. (patent infringement action); and Biota Scientific Ltd. v. Kappos (appeal of USPTO decision re obviousness of pharmaceutical formulation).

Presentations and Publications

  • “General Counsel Speak: Building a Forward-Thinking IP Strategy,” Foley’s Annual IP Conference (October 2022)
  • “Perspectives on the New Normal,” Foley’s Annual IP Conference (October 2021)
  • “Patenting Strategies: The Counsel (Corporate and Private),” FCBA Global Outreach Series (October 2016)
  • “IP Management: Getting It Right in Both Europe and the US,” Innovation for Health Conference (February 2014)
  • “Legal Issues Facing Health Companies in the US Market,” Health & Technology Conference (September 2013)
  • “Hindsight is 20/20: Entrepreneurs Share Viewpoints on What They Wish They’d Known,” Nanotech Commercialization Conference (April 2013)
  • “Intellectual Property,” Wharton Business Law Conference (February 2013)
  • “Intellectual Property Life Cycle Management—Thoughts to Consider in Strategic Patent Protection,” American Chemical Society (August 2012)
  • “Risk vs Value: The Impact of Nanotechnology Environmental Health Safety (EHS) on Business Decisions,” Nanotech Commercialization Conference (April 2012)
  • “What’s ‘natural’ about natural resources? Implications for your IP,” American Chemical Society (March 2011)
  • Talapatra S, Bent S, The Art of Negotiating with U.S. Patent Examiners, A.I.P.P.I. 56(2), (2011)
  • “Negotiating a patent: the art of Examiner interviews,” American Chemical Society (August 2010)
  • Talapatra S, Thompson CB, et al., Elongation Factor-1 alpha Is a Selective Regulator of Growth Factor Withdrawal and ER Stress- induced Apoptosis, Cell Death Differ., 9(8), 2002, 856-61
  • Karnauskas R, Talapatra S, and Rudin C, et al., Bcl-xL and Akt Cooperate to Promote Leukemogenesis In Vivo, Oncogene, 22(5), 2003, 688-98

Thought Leadership

Sunit has authored several legal and scientific publications and is frequently quoted in FDA Week and Inside Health Policy. He also regularly lectures on patent matters, most recently at the 2016 FCBA Global Outreach Series (Paris).

06 October 2023 Events

19th Annual IP Conference

Foley & Lardner LLP is thrilled to present our 19th Annual IP Conference on Friday, October 6, 2023, live and in person from Boston’s Seaport District.
14 October 2022 Events

18th Annual IP Conference

Make plans to join us at Foley’s 18th Annual IP Conference on Friday, October 14, 2022, for another year of strategic IP management, protections, and litigation insights.
12 November 2021 Events

17th Annual IP Conference

Make plans to join us at Foley’s 17th annual IP Conference on Friday, November 12, 2021, for another year of collaborating on strategic IP management, protection, and litigation.
04 June 2019 Events

2019 BIO Reception: Clover Clubs, Cheesesteaks, and Convention Connections

Foley is pleased to host its annual networking reception at the 2019 BIO International Convention in Philadelphia on Tuesday, June 4, in partnership with the Personalized Medicine Coalition.
12 November 2018 Article

Agricultural Bioengineering and Food Manufacturing: Navigating the Regulatory Terrain

Foley Partners Nathan Beaver, Sunit Talapatra and Associate Michael Sweeney co-authored an article for <EM>FoodOnline</EM> titled "Agricultural Bioengineering and Food Manufacturing: Navigating the Regulatory Terrain."
09 July 2018 Article

Agricultural Bioengineering: The Shifting Landscape

The field of bioengineering is rapidly evolving with new tools that allow for simple, efficient, and highly-specific DNA and RNA editing. For instance, CRISPR gene editing, which borrows from the natural defense system of bacteria to cut and alter DNA, has immense potential for use in a variety of agricultural and therapeutic contexts.